Telomere uncapping and alternative lengthening of telomeres

Mechanisms of Ageing and Development

Volumn 129, Issue 1-2, 2008, Pages 99-108

  Cesare, Anthony J ^a,b   Reddel, Roger R ^a,b  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alternative lengthening of telomeres; Cellular immortalization; Homologous recombination; Telomere; Uncapping

Indexed keywords

ALTERNATIVE LENGTHENING OF TELOMERE; ARTICLE; CAPPING PHENOMENON; CELL FUNCTION; CHROMATID EXCHANGE; DNA DAMAGE; DNA REPLICATION; HOMOLOGOUS RECOMBINATION; HUMAN; PRIORITY JOURNAL; TELOMERE;

ANIMALS; HUMANS; MODELS, GENETIC; RECOMBINATION, GENETIC; TELOMERE;

EID: 39049125505     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2007.11.006     Document Type: Article

References (108)

1. Amiard S., Doudeau M., Pinte S., Poulet A., Lenain C., Faivre-Moskalenko C., Angelov D., Hug N., Vindigni A., Bouvet P., Paoletti J., Gilson E., and Giraud-Panis M.J. A topological mechanism for TRF2-enhanced strand invasion. Nat. Struct. Mol. Biol. 14 (2007) 147-154
2. Bae N.S., and Baumann P. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell 26 (2007) 323-334
3. Bailey S.M., Brenneman M.A., and Goodwin E.H. Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res. 32 (2004) 3743-3751
4. Baumann P., and Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292 (2001) 1171-1175
5. Bechter O.E., Zou Y., Shay J.W., and Wright W.E. Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency. EMBO Rep. 4 (2003) 1138-1143
6. Bechter O.E., Shay J.W., and Wright W.E. The frequency of homologous recombination in human ALT cells. Cell Cycle 3 (2004) 547-549
7. Bechter O.E., Zou Y., Walker W., Wright W.E., and Shay J.W. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res. 64 (2004) 3444-3451
8. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., and Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 17 (1997) 236-239
9. Broccoli D., Smogorzewska A., Chong L., and de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17 (1997) 231-235
10. Bryan T.M., Englezou A., Gupta J., Bacchetti S., and Reddel R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14 (1995) 4240-4248
11. Bryan T.M., Englezou A., Dalla-Pozza L., Dunham M.A., and Reddel R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3 (1997) 1271-1274
12. Bucholc M., Park Y., and Lustig A.J. Intrachromatid excision of telomeric DNA as a mechanism for telomere size control in Saccharomyces cerevisiae. Mol. Cell. Biol. 21 (2001) 6559-6573
13. Celli G.B., and de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7 (2005) 712-718
14. Celli G.B., Denchi E.L., and de Lange T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 8 (2006) 885-890
15. Cesare A.J., Quinney N., Willcox S., Subramanian D., and Griffith J.D. Telomere looping in P. sativum (common garden pea). Plant J. 36 (2003) 271-279
16. Cesare A.J., and Griffith J.D. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol. Cell. Biol. 24 (2004) 9948-9957
17. Cesare, A.J., Groff-Vindman, C., Compton, S.A., McEachern, M.J., Griffith, J.D., 2007. Telomere loops and homologous recombination dependent telomeric circles in a Kluyveromyces lactis telomere mutant strain. Mol. Cell. Biol. doi:10.1128/MCB.01122-07, ( Published ahead of print on October 29, 2007).
18. Chang S., Khoo C.M., Naylor M.L., Maser R.S., and DePinho R.A. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev. 17 (2003) 88-100
19. Chen Y.J., Hakin-Smith V., Teo M., Xinarianos G.E., Jellinek D.A., Carroll T., McDowell D., MacFarlane M.R., Boet R., Baguley B.C., Braithwaite A.W., Reddel R.R., and Royds J.A. Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma. Cancer Res. 66 (2006) 6473-6476
20. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., and DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97 (1999) 527-538
21. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P., and de Lange T. A human telomeric protein. Science 270 (1995) 1663-1667
22. Compton S.A., Choi J.H., Cesare A.J., Ozgur S., and Griffith J.D. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res. 67 (2007) 1513-1519
23. Costa A., Daidone M.G., Daprai L., Villa R., Cantu S., Pilotti S., Mariani L., Gronchi A., Henson J.D., Reddel R.R., and Zaffaroni N. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res. 66 (2006) 8918-8924
24. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., and Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11 (1992) 1921-1929
25. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
26. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110
27. Denchi E.L., and de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448 (2007) 1068-1071
28. Dimitrova N., and de Lange T. MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres. Genes Dev. 20 (2006) 3238-3243
29. Dunham M.A., Neumann A.A., Fasching C.L., and Reddel R.R. Telomere maintenance by recombination in human cells. Nat. Genet. 26 (2000) 447-450
30. Fasching C.L., Bower K., and Reddel R.R. Telomerase-independent telomere length maintenance in the absence of ALT-associated PML bodies. Cancer Res. 65 (2005) 2722-2729
31. Fasching C.L., Neumann A.A., Muntoni A., Yeager T.R., and Reddel R.R. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Cancer Res. 67 (2007) 7072-7077
32. Fouche N., Cesare A.J., Willcox S., Ozgur S., Compton S.A., and Griffith J.D. The basic domain of TRF2 directs binding to DNA junctions irrespective of the presence of TTAGGG repeats. J. Biol. Chem. 281 (2006) 37486-37495
33. Grandin N., Damon C., and Charbonneau M. Cdc13 prevents telomere uncapping and Rad50-dependent homologous recombination. EMBO J. 20 (2001) 6127-6139
34. Greider C.W., and Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43 (1985) 405-413
35. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., and de Lange T. Mammalian telomeres end in a large duplex loop. Cell 97 (1999) 503-514
36. 2/M phase of the cell cycle. J. Cell Sci. 113 (2000) 4577-4585
37. Groff-Vindman C., Cesare A.J., Natarajan S., Griffith J.D., and McEachern M.J. Recombination at long mutant telomeres produces tiny single- and double-stranded telomeric circles. Mol. Cell. Biol. 25 (2005) 4406-4412
38. Hakin-Smith V., Jellinek D.A., Levy D., Carroll T., Teo M., Timperley W.R., McKay M.J., Reddel R.R., and Royds J.A. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361 (2003) 836-838
39. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
40. He H., Multani A.S., Cosme-Blanco W., Tahara H., Ma J., Pathak S., Deng Y., and Chang S. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J. 25 (2006) 5180-5190
41. Henson J.D., Neumann A.A., Yeager T.R., and Reddel R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene 21 (2002) 598-610
42. Hockemeyer D., Sfeir A.J., Shay J.W., Wright W.E., and de Lange T. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J. 24 (2005) 2667-2678
43. Hockemeyer D., Daniels J.P., Takai H., and de Lange T. Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 126 (2006) 63-77
44. Houghtaling B.R., Cuttonaro L., Chang W., and Smith S. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 14 (2004) 1621-1631
45. Iyer S., Chadha A.D., and McEachern M.J. A mutation in the STN1 gene triggers an alternative lengthening of telomere-like runaway recombinational telomere elongation and rapid deletion in yeast. Mol. Cell. Biol. 25 (2005) 8064-8073
46. Jiang W.Q., Zhong Z.H., Henson J.D., Neumann A.A., Chang A.C., and Reddel R.R. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of MRE11/RAD50/NBS1 complex. Mol. Cell. Biol. 25 (2005) 2708-2721
47. Jiang W.Q., Zhong Z.H., Henson J.D., and Reddel R.R. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene 26 (2007) 4635-4647
48. Karlseder J., Smogorzewska A., and de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 295 (2002) 2446-2449
49. Kelleher C., Kurth I., and Lingner J. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol. Cell. Biol. 25 (2005) 808-818
50. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
51. Kim S., Kaminker P., and Campisi J. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23 (1999) 405-412
52. Larrivee M., and Wellinger R.J. Telomerase- and capping-independent yeast survivors with alternate telomere states. Nat. Cell Biol. 8 (2006) 741-747
53. Laud P.R., Multani A.S., Bailey S.M., Wu L., Ma J., Kingsley C., Lebel M., Pathak S., DePinho R.A., and Chang S. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 19 (2005) 2560-2570
54. Li B., Oestreich S., and de Lange T. Identification of human Rap1: implications for telomere evolution. Cell 101 (2000) 471-483
55. Lin C.Y., Chang H.H., Wu K.J., Tseng S.F., Lin C.C., Lin C.P., and Teng S.C. Extrachromosomal telomeric circles contribute to Rad52-, Rad50-, and polymerase delta-mediated telomere-telomere recombination in Saccharomyces cerevisiae. Eukaryot. Cell 4 (2005) 327-336
56. Liu D., O'Connor M.S., Qin J., and Songyang Z. Telosome, a mammalian telomere associated complex formed by multiple telomeric proteins. J. Biol. Chem. 279 (2004) 51338-51342
57. Liu D., Safari A., O'Connor M.S., Chan D.W., Laegeler A., Qin J., and Songyang Z. PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 6 (2004) 673-680
58. Loayza D., Parsons H., Donigian J., Hoke K., and de Lange T. DNA binding features of human POT1: a nonamer 5′-TAGGGTTAG-3′ minimal binding site, sequence specificity, and internal binding to multimeric sites. J. Biol. Chem. 279 (2004) 13241-13248
59. Londono-Vallejo J.A., Der-Sarkissian H., Cazes L., Bacchetti S., and Reddel R.R. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res. 64 (2004) 2324-2327
60. Lustig A.J. Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion. Nat. Rev. Cancer 4 (2003) 916-923
61. Makarov V.L., Hirose Y., and Langmore J.P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88 (1997) 657-666
62. Marciniak R.A., Cavazos D., Montellano R., Chen Q., Guarente L., and Johnson F.B. A novel telomere structure in human alternative lengthening of telomeres cell line. Cancer Res. 65 (2005) 2730-2737
63. McEachern M.J., and Iyer S. Short telomeres in yeast are highly recombinogenic. Mol. Cell 7 (2001) 695-704
64. Molenaar C., Wiesmeijer K., Verwoerd N.P., Khazen S., Eils R., Tanke H.J., and Dirks R.W. Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J. 22 (2003) 6631-6641
65. n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6622-6626
66. Munoz-Jordan J.L., Cross G.A., de Lange T., and Griffith J.D. T-loops at trypanosome telomeres. EMBO J. 20 (2001) 579-588
67. Muntoni A., and Reddel R.R. The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 14 Suppl. 2 (2005) R191-R196
68. Murnane J.P., Sabatier L., Marder B.A., and Morgan W.F. Telomere dynamics in an immortal human cell line. EMBO J. 13 (1994) 4953-4962
69. Murti K.G., and Prescott D.M. Telomeres of polytene chromosomes in a ciliated protozoan terminate in duplex DNA loops. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 14436-14439
70. Nabetani A., Yokoyama O., and Ishikawa F. Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J. Biol. Chem. 279 (2004) 25849-25857
71. Natarajan S., and McEachern M.J. Recombinational telomere elongation promoted by DNA circles. Mol. Cell. Biol. 22 (2002) 4512-4521
72. Natarajan S., Groff-Vindman C., and McEachern M.J. Factors influencing the recombinational expansion and spread of telomeric tandem arrays in Kluyveromyces lactis. Eukaryot. Cell 2 (2003) 1115-1127
73. Nikitina T., and Woodcock C.L. Closed chromatin loops at the ends of chromosomes. J. Cell Biol. 166 (2004) 161-165
74. Nosek J., Rycovska A., Makhov A.M., Griffith J.D., and Tomaska L. Amplification of telomeric arrays via rolling-circle mechanism. J. Biol. Chem. 280 (2005) 10840-10845
75. Ogino H., Nakabayashi K., Suzuki M., Takahashi E.I., Fujii M., Suzuki T., and Ayusawa D. Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem. Biophys. Res. Commun. 248 (1998) 223-227
76. Olovnikov A.M. Principle of marginotomy in template synthesis of polynucleotides. Doklady Akademii Nauk SSR 201 (1971) 1496-1499
77. Perrem K., Bryan T.M., Englezou A., Hackl T., Moy E.L., and Reddel R.R. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18 (1999) 3383-3390
78. Potts P.R., and Yu H. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat. Struct. Mol. Biol. 14 (2007) 581-590
79. Riha K., Watson J.M., Parkey J., and Shippen D.E. Telomere length deregulation and enhanced sensitivity to genotoxic stress in Arabidopsis mutants deficient in Ku70. EMBO J. 21 (2002) 2819-2826
80. Scheel C., Schaefer K.L., Jauch A., Keller M., Wai D., Brinkschmidt C., van Valen F., Boecker W., Dockhorn-Dworniczak B., and Poremba C. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20 (2001) 3835-3844
81. Shay J.W., Pereira-Smith O.M., and Wright W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196 (1991) 33-39
82. Shay J.W., and Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33 (1997) 787-791
83. Silverman J., Takai H., Buonomo S.B., Eisenhaber F., and de Lange T. Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. Genes Dev. 18 (2004) 2108-2119
84. Smogorzewska A., and de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21 (2002) 4338-4348
85. Smogorzewska A., Karlseder J., Holtgreve-Grez H., Jauch A., and de Lange T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 12 (2002) 1635-1644
86. Stansel R.M., de Lange T., and Griffith J.D. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J. 20 (2001) 5532-5540
87. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13 (2003) 1549-1556
88. Tarsounas M., Munoz P., Claas A., Smiraldo P.G., Pittman D.L., Blasco M.A., and West S.C. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117 (2004) 337-347
89. Teng S.C., Chang J., McCowan B., and Zakian V.A. Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol. Cell 6 (2000) 947-952
90. Tokutake Y., Matsumoto T., Watanabe T., Maeda S., Tahara H., Sakamoto S., Niida H., Sugimoto M., Ide T., and Furuichi Y. Extra-chromosome telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247 (1998) 765-772
91. Tomaska L., Nosek J., Makhov A.M., Pastorakova A., and Griffith J.D. Extragenomic double-stranded DNA circles in yeast with linear mitochondrial genomes: potential involvement in telomere maintenance. Nucleic Acids Res. 28 (2000) 4479-4487
92. Topcu Z., Nickles K., Davis C., and McEachern M.J. Abrupt disruption of capping and a single source for recombinationally elongated telomeres in Kluyveromyces lactis. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 3348-3353
93. Underwood D.H., Carroll C., and McEachern M.J. Genetic dissection of the Kluyveromyces lactis telomere and evidence for telomere capping defects in TER1 mutants with long telomeres. Eukaryot. Cell 3 (2004) 369-384
94. van Steensel B., Smogorzewska A., and de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 92 (1998) 401-413
95. Verdun R.E., Crabbe L., Haggblom C., and Karlseder J. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol. Cell 20 (2005) 551-561
96. Verdun R.E., and Karlseder J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127 (2006) 709-720
97. Wang R.C., Smogorzewska A., and de Lange T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119 (2004) 355-368
98. Watson J.D. Origin of concatemeric T7 DNA. Nat. New Biol. 239 (1972) 197-201
99. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., and Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18 (1996) 173-179
100. Wu G., Lee W.H., and Chen P.L. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phrases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275 (2000) 30618-30622
101. Wu L., Multani A.S., He H., Cosme-Blanco W., Deng Y., Deng J.M., Bachilo O., Pathak S., Tahara H., Bailey S.M., Deng Y., Behringer R.R., and Chang S. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126 (2006) 49-62
102. Ye J.Z., Hockemeyer D., Krutchinsky A.N., Loayza D., Hooper S.M., Chait B.T., and de Lange T. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 18 (2004) 1649-1654
103. Yeager T.R., Neumann A.A., Englezou A., Huschtscha L.I., Noble J.R., and Reddel R.R. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59 (1999) 4175-4179
104. Yui J., Chiu C.P., and Lansdorp P.M. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 91 (1998) 3255-3262
105. Zellinger B., Akimcheva S., Puizina J., Schirato M., and Riha K. Ku suppresses formation of telomeric circles and alternative telomere lengthening in Arabidopsis. Mol. Cell 27 (2007) 163-169
106. Zhong Z.H., Jiang W.Q., Cesare A.J., Neumann A.A., Wadhwa R., and Reddel R.R. Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J. Biol. Chem. 282 (2007) 29314-29322
107. Zhu X.D., Kuster B., Mann M., Petrini J.H., and de Lange T. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 25 (2000) 347-352
108. Zhu X.D., Niedernhofer L., Kuster B., Mann M., Hoeijmakers J.H., and de Lange T. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 12 (2003) 1489-1498